Using topiramate in patients with epilepsy: Practical aspects

Canadian Journal of Neurological Sciences

Volumn 25, Issue 3, 1998, Pages

  Sander, J W A S ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; TOPIRAMATE;

ANTICONVULSANT THERAPY; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; FOCAL EPILEPSY; HUMAN; MAJOR CLINICAL STUDY; NEPHROLITHIASIS; NEUROTOXICITY; PATIENT COUNSELING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SEIZURE; SOMNOLENCE; WEIGHT REDUCTION;

EID: 0031848829     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/s0317167100034867     Document Type: Conference Paper

References (11)

1. Walker MC, Sander JWAS. Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology 1997; 49: 333-337.
2. Walker MC, Sander JWAS, The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal. Neurology 1996; 46: 912-914.
3. Faught E, Wilder BJ, Ramsay RE, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996; 46: 1684- 1690.
4. Privitera M, Fincham R, Penry J, et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-. 800-, and 1,000-mg daily dosages. Neurology 1996; 46: 1678- 1683.
5. Ben-Menachem E, Henriksen O, Dam M, et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996; 37; 539- 543.
6. Sachdeo R, Reife R, Lim P, Pledger G. Single-center topiramate monotherapy trial. Epilepsia 1995; 36 (Suppl 3): 151.
7. Biton V. Preliminary open-label experience with topiramate in primary generalized seizures. Epilepsia 1997; 38(Suppl 1): S42-S45.
8. Espe-Lillo J, Ritter FJ, Frost MD, Spiegel RH, Reife R. Topiramate in childhood epilepsy: titration, adverse events, and efficacy in multiple seizure types. Epilepsia 1995; 36 (Suppl 4): 56.
9. Shorvon S. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 1996; 37 (Suppl 2): 18-22.
10. Bourgeois BFD. Drug interaction profile of topiramate. Epilepsia 1996; 37 (Suppl 2): 14-17.
11. Walker MC, Sander JWAS. Topiramate: a new antiepileptic drug for refractory epilepsy. Seizure 1996; 5: 199-203.